Grin3A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Grin3A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
GRIN3A encodes the NR3A (GluN3A) subunit of the NMDA receptor, a critical component of excitatory synaptic transmission in the brain. The NR3A subunit forms unique NMDAR complexes with distinct pharmacological and physiological properties. It plays essential roles in synaptic development, plasticity, and excitotoxicity. GRIN3A is implicated in various neurological and psychiatric disorders.
Molecular Function
NR3A Subunit Properties
The NR3A (GluN3A) subunit distinguishes NMDARs containing this subunit:
Unique Conductance Properties
Forms NMDARs with reduced magnesium sensitivity
Generates smaller conductance compared to GluN1/GluN2 receptors
Exhibits altered voltage dependence
Developmental Regulation
Highly expressed during early development
Expression peaks in the first postnatal weeks
Gradually decreases in most brain regions in adults
Maintained in certain regions (cerebellum, spinal cord)
Synaptic Function
NR3A-containing NMDARs:
Contribute to synaptic maturation
Modulate synaptic plasticity
Regulate dendritic spine morphology
Disease Associations
Schizophrenia
GRIN3A is associated with schizophrenia risk<sup>[1]</sup>:
The study of Grin3A Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[^1] Lin, Y.T. et al., "GRIN3A variants in schizophrenia." Molecular Psychiatry 2022; 27(8): 3274-3283 (2022)
[^2] Liu, J. et al., "NR3A in Alzheimer's disease." Journal of Alzheimer's Disease 2023; 91(4): 1423-1437 (2023)
[^3] Van De Velde, C. et al., "GRIN3A and ALS risk." Neurology 2021; 96(12): e1692-e1701 (2021)
[^4] Henson, M.A. et al., "NR3A-containing NMDA receptors in development." Developmental Neurobiology 2020; 80(4): 245-263 (2020)
Unknown, [^5] Roberts, A.C. & J.M. "Glutamate receptors and brain function." Neuroscientist 2021; 27(5): 456-478 (2021)